News Industry News Resverlogix Officially Attains Phase 3 Status with a European Regulatory Authority June 22, 2015
News Industry News Takeda Presents Additional Data from Alogliptin's EXAMINE Cardiovascular Safety Outcomes Trial at the American Diabetes Association's 75th Scientific Sessions June 05, 2015